iPLATO Hub to Help Government Boost Uptake of NHS Health Checks

iPLATO HealthcareiPLATO Healthcare, a UK leader in cloud based mHealth and Analytics, welcomes the new government mandate to re-launch NHS Health Checks to reach 15 million patients over the next 5 years. In a number of trials in recent years the iPLATO service has proven to help engage target patients around NHS Health Checks and cost effectively reach screening targets. iPLATO states its commitment to help Public Health England reach its ambitious target through further development to its iPLATO Hub product to include letter and phone calls in addition to its existing mix of digital engagement - SMS, Apps and Video.

"NHS Health Checks has been a popular campaign for our Public Health and GP Practice partners for some time," says Tobias Alpsten, CEO of iPLATO. "Practices use iPLATO to engage patients and invite for NHS Health Checks every year. Using iPLATO Hub, local and regional Public Health teams can tap into this existing communication capability and transform overall performance through very sophisticated multi-channel campaigns. This is a huge step up from traditionally laborious processes for informing patients about NHS Health Checks and inviting them to book an appointment."

Kim, IT Manager at Brondesbury Medical Centre, an iPLATO user says, "Mobile phones are used by most of our patients and so text messaging is an effective way to communicate with them especially around NHS Health Checks. This service has the potential to significantly increase the number of patients attending clinics as well as saving on surgery administration costs."

In a document laying out its priorities for 2013-16 Public Health England said all 40 to 74 year olds will be offered health checks, which were introduced in 2009 with the aim of preventing heart disease, stroke, diabetes, kidney disease and certain types of dementia. Public Health England said one of its priorities was to reduce preventable deaths and to do this it would 'support people to live healthier lives by implementing NHS Health Checks to 15 million eligible people.'

Related news articles:

About iPLATO
iPLATO Healthcare is British innovation company. iPLATO’s evidence based mobile health solutions have proven to improve patient access to healthcare, to enable powerful health promotion targeted at people at risk and to support people with long term conditions.

Serving millions of patients and thousands of healthcare professionals every day iPLATO has emerged as the leader in mobile health. Across this network the company is running campaigns to promote smoking cessation, weight loss, childhood immunisation and pandemic awareness as well as mobile disease management services for people with diabetes, hypertension, epilepsy and HIV.

iPLATO Healthcare's mission is to, in partnership with clinicians, help healthcare commissioners transform patient care through cloud based mHealth and Analytics.

Most Popular Now

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

OmicsFootPrint: Mayo Clinic's AI To…

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool...

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

Testing AI with AI: Ensuring Effective A…

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialled in South Australian hospitals actually has the potential to assist doctors and...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...